INDIVIDUAL-DIFFERENCES IN HYPOTHALAMIC-PITUITARY-ADRENAL ACTIVITY IN LATER LIFE AND HIPPOCAMPAL AGING

被引:86
作者
MEANEY, MJ
ODONNELL, D
ROWE, W
TANNENBAUM, B
STEVERMAN, A
WALKER, M
NAIR, NPV
LUPIEN, S
机构
[1] DOUGLAS HOSP, AGING RES PROGRAM, MONTREAL, PQ H4H 1R3, CANADA
[2] MCGILL UNIV, DEPT PSYCHIAT, MONTREAL, PQ, CANADA
[3] MCGILL UNIV, DEPT NEUROL & NEUROSURG, MONTREAL, PQ, CANADA
关键词
GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; NEURON LOSS; AGING; HIPPOCAMPUS;
D O I
10.1016/0531-5565(94)00065-B
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Variation in magnitude of cognitive decline in later life is a central feature of human aging. The more severe forms of dementias, such as Alzheimer's disease, clearly define one end of the spectrum. However, among those showing no obvious signs of clinical dementia there are considerable individual differences. Thus, although evidence for learning, memory, and language loss appears in some individuals as early as 50-55 years of age, many people continue to function alertly well into their 90s. These individuals exemplify what Rowe and Kahn (1987) have termed ''successful'' aging. The wide variability in CNS aging, often a nuisance factor in studies, are becoming a major focus for brain aging research (e.g., Gage et al., 1984; Gallager and Pelleymounter, 1988; Aitken and Meaney, 1990; Issa et al., 1990). Our studies over the past few years have added support to the idea that individual differences in hypothalamic-pituitary-adrenal (HPA) activity can account for part of the variation seen in neurological function among the elderly. In this article we discuss the evidence for the idea that adrenal glucocorticoids can compromise hippocampal function and, thus, produce cognitive impairments, as well as the potential mechanisms for these effects.
引用
收藏
页码:229 / 251
页数:23
相关论文
共 125 条
[61]   PLACE NAVIGATION IMPAIRED IN RATS WITH HIPPOCAMPAL-LESIONS [J].
MORRIS, RGM ;
GARRUD, P ;
RAWLINS, JNP ;
OKEEFE, J .
NATURE, 1982, 297 (5868) :681-683
[62]   PHYSIOLOGICAL FUNCTIONS OF GLUCOCORTICOIDS IN STRESS AND THEIR RELATION TO PHARMACOLOGICAL ACTIONS [J].
MUNCK, A ;
GUYRE, PM ;
HOLBROOK, NJ .
ENDOCRINE REVIEWS, 1984, 5 (01) :25-44
[63]  
NAIR NPV, UNPUB CIRCADIAN RHYT
[64]   ENTORHINAL CORTEX LESIONS TRANSIENTLY ALTER GLUCOCORTICOID BUT NOT MINERALOCORTICOID RECEPTOR GENE-EXPRESSION IN THE RAT HIPPOCAMPUS [J].
ODONNELL, D ;
BACCICHET, A ;
SECKL, JR ;
MEANEY, MJ ;
POIRIER, J .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (01) :356-359
[65]   SELECTIVE CORTICOSTEROID ANTAGONISTS MODULATE SPECIFIC ASPECTS OF SPATIAL ORIENTATION LEARNING [J].
OITZL, MS ;
DEKLOET, ER .
BEHAVIORAL NEUROSCIENCE, 1992, 106 (01) :62-71
[66]   CEREBRAL ATROPHY FOLLOWING ACTH THERAPY [J].
OKUNO, T ;
ITO, M ;
KONISHI, Y ;
YOSHIOKA, M ;
NAKANO, Y .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1980, 4 (01) :20-23
[67]   GLUCOCORTICOID ENDANGERMENT OF THE HIPPOCAMPUS - TISSUE, STEROID AND RECEPTOR SPECIFICITY [J].
PACKAN, DR ;
SAPOLSKY, RM .
NEUROENDOCRINOLOGY, 1990, 51 (06) :613-618
[68]   AGE-RELATED-CHANGES IN GLUCOCORTICOID RECEPTOR-BINDING AND MESSENGER-RNA LEVELS IN THE RAT-BRAIN AND PITUITARY [J].
PEIFFER, A ;
BARDEN, N ;
MEANEY, MJ .
NEUROBIOLOGY OF AGING, 1991, 12 (05) :475-479
[69]  
PEPIN MC, 1992, MOL PHARMACOL, V41, P1016
[70]   IMPAIRED TYPE-II GLUCOCORTICOID-RECEPTOR FUNCTION IN MICE BEARING ANTISENSE RNA TRANSGENE [J].
PEPIN, MC ;
POTHIER, F ;
BARDEN, N .
NATURE, 1992, 355 (6362) :725-728